JAMA Oncology : Therapy and Survival Patterns in Patients With Stage 2/3 Rectal Cancer Treated With Trimodality Therapy
Interview with Hagen F. Kennecke, MD, author of Patterns of Practice and Improvements in Survival Among Patients With Stage 2/3 Rectal Cancer Treated With Trimodality Therapy. Hosted by Jack West, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - August 18, 2022 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Oncology : Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer
Interview with Emmanouil Fokas, MD, DPhil, author of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial. Hosted by Jack West, MD. (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - November 18, 2021 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Adjuvant Chemotherapy for Rectal Cancer | Possibly Use Single-Agent Capecitabine
Fa-Chyi Lee, MD, UC Irvine Health, talks about Adjuvant Chemotherapy for Rectal Cancer | Possibly Use Single-Agent Capecitabine at MOASC 2018<br />
Author: moasc
Added: 08/23/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 23, 2018 Category: Cancer & Oncology Source Type: podcasts
Future prospects for treating rectal cancer
Kai-Keen Shiu, MRCP, PhD, of University College London Hospitals NHS Foundation Trust, London, UK, speaks to us about future directions for the treatment of rectal cancer at the UK Oncology Forum (OF)...
Author: VJOncology
Added: 07/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 6, 2018 Category: Cancer & Oncology Source Type: podcasts
Rectal cancer watch & wait
Can patients with rectal cancer safely avoid surgery? Jessamy Bagenal of The Lancet interviews Geerard Beets about findings from the International Watch& Wait Database. (Source: Listen to The Lancet)
Source: Listen to The Lancet - June 22, 2018 Category: General Medicine Authors: The Lancet Source Type: podcasts
Debate: Is observation without surgery reasonable for rectal cancers achieving a clinical CR? - No
In this presentation from the 2017 Great Debates & Updates in GI Malignancies, Dr. Christopher L. Hallemeier argues that observation without surgery is not reasonable for rectal cancers that have achi...
Author: imedex
Added: 10/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 13, 2017 Category: Cancer & Oncology Source Type: podcasts
Debate: Is observation without surgery reasonable for rectal cancers achieving a clinical CR? - Yes
In this presentation from the 2017 Great Debates & Updates in GI Malignancies, Dr. Julio Garcia-Aguilar argues that observation without surgery is reasonable for rectal cancers that have achieved a cl...
Author: imedex
Added: 10/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 13, 2017 Category: Cancer & Oncology Source Type: podcasts
Overview of Phase II Multicenter Randomized Trial in Rectal Cancer
Christopher Leigh Hallemeier, MD of Mayo Clinic gives an overview of Dr. Julio Garcia-Aguilar's latest research trial, A Phase II Multicenter Randomized Trial Evaluating 3-year Disease Free Survival i...
Author: GiDebates2017
Added: 05/25/2017 (Source: Oncology Tube)
Source: Oncology Tube - May 25, 2017 Category: Cancer & Oncology Source Type: podcasts
Debate: Is Observation Without Surgery Reasonable for Rectal Cancers Achieving a Clinical CR?
Christopher Leigh Hallemeier, MD of Mayo Clinic gives an overview of his presentation, Is Observation Without Surgery Reasonable for Rectal Cancers Achieving a Clinical CR, which was debated at the 20...
Author: GiDebates2017
Added: 05/25/2017 (Source: Oncology Tube)
Source: Oncology Tube - May 25, 2017 Category: Cancer & Oncology Source Type: podcasts
Can We Use Non-Operative Management for Stage I Rectal Cancer Patients?
Christopher Leigh Hallemeier, MD of Mayo Clinic explains whether or not clinicians can use non-operative management for patients with stage I rectal cancer. This was recorded at the 2017 Great Debates...
Author: GiDebates2017
Added: 05/25/2017 (Source: Oncology Tube)
Source: Oncology Tube - May 25, 2017 Category: Cancer & Oncology Source Type: podcasts
New Data on Watch-and-Wait Protocols in Rectal Cancer
Julio Garcia-Aguilar, MD, PhD of Memorial Sloan-Kettering gives an overview of new data regarding watch-and-wait approaches in patients with rectal cancer. This was recorded at the 2017 Great Debates ...
Author: GiDebates2017
Added: 05/25/2017 (Source: Oncology Tube)
Source: Oncology Tube - May 25, 2017 Category: Cancer & Oncology Source Type: podcasts
Debate: Is Observation Without Surgery Reasonable for Rectal Cancers Achieving a Clinical CR?
Julio Garcia-Aguilar, MD, PhD of Memorial Sloan-Kettering gives an overview of his presentation, Is Observation Without Surgery Reasonable for Rectal Cancers Achieving a Clinical CR, which was debated...
Author: GiDebates2017
Added: 05/25/2017 (Source: Oncology Tube)
Source: Oncology Tube - May 25, 2017 Category: Cancer & Oncology Source Type: podcasts
PodMed – Week of May 1, 2017
This week’s topics include managing preeclampsia, diet soft drinks and stroke, autoimmune conditions and malaria, and fecal immunochemical testing and colorectal cancer. Program notes: 0:36 Malaria, lupus and MS 1:36 B-cell activating factor or BAF 2:34 Sickle cell anemia also 3:16 Diet soft drinks and stroke 4:16 Three fold increased risk of stroke and Alzheimer’s […] (Source: Johns Hopkins Medicine Weekly Health News)
Source: Johns Hopkins Medicine Weekly Health News - April 28, 2017 Category: Consumer Health News Authors: Elizabeth Tracey Johns Hopkins Medicine Tags: All Podcasts Alzheimer's Disease And Dementia Chronic Disease Colon And Rectal Cancer Genetics Geriatrics High Blood Pressure Neurology And Neurosurgery PodMed Pregnancy Source Type: podcasts
Novel Agents and Proton Beam Therapy studies may be on the horizon for Locally Recurrent Rectal Cancer
Theodore S. Hong, MD of Massachusetts General Hospital outlines how Novel Agents and Proton Beam Therapy studies may be on the horizon for Locally Recurrent Rectal Cancer at ASCO GI 2017.
Author: ASCOGI2017
Added: 01/26/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2017 Category: Cancer & Oncology Source Type: podcasts
